{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:32:07Z","timestamp":1789821127585,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejphar.2025.177343","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T15:49:06Z","timestamp":1738424946000},"page":"177343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation"],"prefix":"10.1016","volume":"991","author":[{"given":"Yunduo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-905X","authenticated-orcid":false,"given":"Linhai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177343_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2024\/1841909","article-title":"Exploring anti-breast cancer effects of live Pediococcus acidilactici and its cell-free supernatant isolated from human breast milk","author":"Adumuah","year":"2024","journal-title":"Int. J. Breast Cancer"},{"key":"10.1016\/j.ejphar.2025.177343_bib2","doi-asserted-by":"crossref","first-page":"D679","DOI":"10.1093\/nar\/gkad960","article-title":"WikiPathways 2024: next generation pathway database","volume":"52","author":"Agrawal","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib3","article-title":"The gene Ontology knowledgebase in 2023","volume":"224","author":"Aleksander","year":"2023","journal-title":"Genetics"},{"key":"10.1016\/j.ejphar.2025.177343_bib4","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2019.10425","article-title":"Chidamide suppresses the glycolysis of triple negative breast cancer cells partially by targeting the miR-33a-5p-LDHA axis","author":"Bai","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2025.177343_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/annonc\/mdy024","article-title":"Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis","volume":"29","author":"Bareche","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2025.177343_bib6","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejphar.2025.177343_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcancer.2024.01.003","article-title":"The obesity-autophagy-cancer axis: mechanistic insights and therapeutic perspectives","volume":"99","author":"Behrooz","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2025.177343_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.15","article-title":"ImmPort, toward repurposing of open access immunological assay data for translational and clinical research","volume":"5","author":"Bhattacharya","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.ejphar.2025.177343_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113032","article-title":"Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma","volume":"150","author":"Bishayee","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177343_bib10","first-page":"1","article-title":"Landscape of microsatellite instability across 39 cancer types","author":"Bonneville","year":"2017","journal-title":"JCO Precision Oncol."},{"key":"10.1016\/j.ejphar.2025.177343_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177343_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102247","article-title":"Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer","volume":"9","author":"Bottosso","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejphar.2025.177343_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.177343_bib14","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2025.177343_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2025.177343_bib17","series-title":"Cancer Systems Biology: Methods and Protocols","first-page":"243","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","author":"Chen","year":"2018"},{"key":"10.1016\/j.ejphar.2025.177343_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216235","article-title":"MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer","volume":"565","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.177343_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02928-2","article-title":"RGCC-mediated PLK1 activity drives breast cancer lung metastasis by phosphorylating AMPK\u03b12 to activate oxidative phosphorylation and fatty acid oxidation","volume":"42","author":"Cheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/pharmrev.122.000665","article-title":"Newly developed targeted therapies against the androgen receptor in triple-negative breast cancer: a Review","volume":"75","author":"Choupani","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2025.177343_bib21","doi-asserted-by":"crossref","first-page":"D138","DOI":"10.1093\/nar\/gkad965","article-title":"NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update","volume":"52","author":"Clough","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01643-5","article-title":"Signaling, cancer cell plasticity, and intratumor heterogeneity","volume":"22","author":"Cordani","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2025.177343_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2025.177343_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101307","article-title":"Mitochondrial calcium uniporter regulates PGC-1\u03b1 expression to mediate metabolic reprogramming in pulmonary fibrosis","volume":"26","author":"Gu","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.177343_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejphar.2025.177343_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612638","article-title":"Targeting heat shock protein 27 and fatty acid oxidation augments cisplatin treatment in cisplatin-resistant ovarian cancer cell lines","volume":"24","author":"Heiserman","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177343_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154800","article-title":"Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells","volume":"120","author":"Hu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2025.177343_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","article-title":"The cancer genome atlas: creating lasting value beyond its data","volume":"173","author":"Hutter","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177343_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168496","article-title":"Mechanisms of translation-coupled quality control","volume":"436","author":"Inada","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.177343_bib30","article-title":"Probiotic potential and anticancer properties of Pediococcus sp. isolated from traditional dairy products","volume":"29","author":"Jafari-Nasab","year":"2021","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.ejphar.2025.177343_bib31","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.177343_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172719","article-title":"Omics analysis of chemoresistant triple negative breast cancer cells reveals novel metabolic vulnerabilities","volume":"11","author":"Kordias","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177343_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179507","article-title":"More than meets the eye regarding cancer metabolism","volume":"22","author":"Kubicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177343_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jare.2023.02.005","article-title":"A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer","volume":"54","author":"Kumar","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10549-021-06242-3","article-title":"Spectrum of PIK3CA\/AKT mutations across molecular subtypes of triple-negative breast cancer","volume":"187","author":"Kumar","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2025.177343_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2025.177343_bib38","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177343_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.177343_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-02126-9","article-title":"Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.177343_bib41","article-title":"Tumor cell\u2010intrinsic CD96 mediates chemoresistance and cancer stemness by regulating mitochondrial fatty acid \u03b2\u2010oxidation","volume":"10","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2025.177343_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110870","article-title":"Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.177343_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-023-00531-4","article-title":"Calcifications in triple-negative breast cancer: molecular features and treatment strategies","volume":"9","author":"Lin","year":"2023","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.ejphar.2025.177343_bib44","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jgg.2016.12.004","article-title":"ONGene: a literature-based database for human oncogenes","volume":"44","author":"Liu","year":"2017","journal-title":"J. Genetics Genomics"},{"key":"10.1016\/j.ejphar.2025.177343_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302878120","article-title":"CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing","volume":"120","author":"Liu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2025.177343_bib47","article-title":"Loss of OVOL2 in triple\u2010negative breast cancer promotes fatty acid oxidation fueling stemness characteristics","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2025.177343_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ph15060667","article-title":"HDAC inhibitors for the therapy of triple negative breast cancer","volume":"15","author":"Maccallini","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2025.177343_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177343_bib50","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00147.2023","article-title":"Spatiotemporally quantitative in vivo imaging of mitochondrial fatty acid \u03b2-oxidation at cellular-level resolution in mice","volume":"325","author":"Matsumoto","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2025.177343_bib51","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib52","doi-asserted-by":"crossref","first-page":"11255","DOI":"10.21037\/apm-21-1139","article-title":"Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer","volume":"10","author":"Meng","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.ejphar.2025.177343_bib53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177343_bib54","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/cncr.35229","article-title":"Gut microbiome in association with chemotherapy\u2010induced toxicities among patients with breast cancer","volume":"130","author":"Nguyen","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2025.177343_bib55","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI129049","article-title":"HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models","volume":"130","author":"Nguyen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177343_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1443399","article-title":"Racial\/ethnic differences in the clinical presentation and survival of breast cancer by subtype","volume":"14","author":"Nhim","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.177343_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","article-title":"The great immune escape: understanding the divergent immune response in breast cancer subtypes","volume":"13","author":"Onkar","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2025.177343_bib58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41573-022-00415-5","article-title":"Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment","volume":"21","author":"Petroni","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177343_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176063","article-title":"A promising future in cancer immunotherapy: oncolytic viruses","volume":"960","author":"Seyed-Khorrami","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177343_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2347757","article-title":"Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation","volume":"16","author":"Su","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2025.177343_bib61","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2025.177343_bib62","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation Connectivity Map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177343_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932914","article-title":"Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177343_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105482","article-title":"Metabolic contrasts: fatty acid oxidation and ketone bodies in healthy brains vs. glioblastoma multiforme","volume":"25","author":"Tamas","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177343_bib65","article-title":"Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177343_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177343_bib67","doi-asserted-by":"crossref","first-page":"14644","DOI":"10.1021\/acsnano.2c05263","article-title":"In situ transformable supramolecular nanomedicine targeted activating hippo pathway for triple-negative breast cancer growth and metastasis inhibition","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2025.177343_bib68","article-title":"CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation","volume":"vol. 114","author":"Wright","year":"2017"},{"key":"10.1016\/j.ejphar.2025.177343_bib69","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ejphar.2025.177343_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.523","article-title":"p38\u03b1 MAPK antagonizing JNK to control the hepatic fat accumulation in pediatric patients onset intestinal failure","volume":"8","author":"Xiao","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177343_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-023-00497-9","article-title":"Combined in vitro\/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance","volume":"12","author":"Yan","year":"2023","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejphar.2025.177343_bib72","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177343_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177343_bib74","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177343_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176304","article-title":"Roles of PPAR activation in cancer therapeutic resistance: implications for combination therapy and drug development","volume":"964","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177343_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2025.177343_bib77","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1152\/ajpheart.00877.2012","article-title":"Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1\u03b1","volume":"305","author":"Zhu","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:00:06Z","timestamp":1740484806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":77,"alternative-id":["S0014299925000962"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177343","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177343"}}